By Matt Grossman

Medtronic PLC has been given de novo clearance from the U.S. Food and Drug Administration for its artificial-intelligence tool to detect colorectal polyps, the company said Monday.

The tool, called GI Genius, applies computer-aided detection to colonoscope videos to identify polyps that may develop into cancer.

In studies, the tool has increased the number of polyps that are detected compared with scanning by the human eye alone. Increasing polyp detection has been shown to decrease the risk of colorectal cancer, Medtronic said.

Write to Matt Grossman at matt.grossman@wsj.com

(END) Dow Jones Newswires

April 12, 2021 08:58 ET (12:58 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Medtronic Charts.
Medtronic (NYSE:MDT)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Medtronic Charts.